Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 184 participants.
Also called NCT01294748
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 184 participants
- Sponsor
- Registry
-
NCT01294748
-
- Other papers using this trial's data
- Bioabsorbable polymer-coated sirolimus-eluting stent implantation preserves coronary vasomotion: A DESSOLVE II trial sub-study
- Randomised study of a bioabsorbable polymer-coated sirolimus-eluting stent: results of the DESSOLVE II trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Belgium, France, Netherlands, New Zealand, Sweden, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01294748. Randomized; single masking; primary purpose treatment. Start 2011-02 (registry gives no type); primary completion 2012-06 (actual). Results posted on 2014-03-26.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease
- Acronym
- DESSOLVE-II
- Condition
- Coronary Artery Disease
- Intervention (Device)
- MiStent DES
- Intervention (Device)
- Endeavor DES
- Lead sponsor
- Micell Technologies
Record details
- Record id
cardio:ct-nct01294748- Content hash
dd51327c0b311b88b0e3b5d3d9857b00db2febcb9b4c757503ac77ef1475971f